233 related articles for article (PubMed ID: 32279025)
1. Checkpoint inhibitors for the treatment of JC virus-related progressive multifocal leukoencephalopathy.
Beck ES; Cortese I
Curr Opin Virol; 2020 Feb; 40():19-27. PubMed ID: 32279025
[TBL] [Abstract][Full Text] [Related]
2. Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease.
Cortese I; Reich DS; Nath A
Nat Rev Neurol; 2021 Jan; 17(1):37-51. PubMed ID: 33219338
[TBL] [Abstract][Full Text] [Related]
3. Progressive multifocal leukoencephalopathy: new concepts.
Lima MA
Arq Neuropsiquiatr; 2013 Sep; 71(9B):699-702. PubMed ID: 24141508
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of Immune Checkpoint Inhibitors in Transplant Recipients with Progressive Multifocal Leukoencephalopathy.
Medrano C; Vergez F; Mengelle C; Faguer S; Kamar N; Del Bello A
Emerg Infect Dis; 2019 Nov; 25(11):2145-2147. PubMed ID: 31625858
[TBL] [Abstract][Full Text] [Related]
5. A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy.
Du Pasquier RA; Kuroda MJ; Zheng Y; Jean-Jacques J; Letvin NL; Koralnik IJ
Brain; 2004 Sep; 127(Pt 9):1970-8. PubMed ID: 15215217
[TBL] [Abstract][Full Text] [Related]
6. Immune checkpoint inhibitors for progressive multifocal leukoencephalopathy: a new gold standard?
Roos-Weil D; Weiss N; Guihot A; Uzunov M; Bellanger A; Eymard B; Saadoun D; Houillier C; Idbaih A; Demeret S; Deback C; Leblond V; Galanaud D; Shor N; Pourcher V
J Neurol; 2021 Jul; 268(7):2458-2465. PubMed ID: 33515299
[TBL] [Abstract][Full Text] [Related]
7. Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy.
Cortese I; Muranski P; Enose-Akahata Y; Ha SK; Smith B; Monaco M; Ryschkewitsch C; Major EO; Ohayon J; Schindler MK; Beck E; Reoma LB; Jacobson S; Reich DS; Nath A
N Engl J Med; 2019 Apr; 380(17):1597-1605. PubMed ID: 30969503
[TBL] [Abstract][Full Text] [Related]
8. Progressive multifocal leukoencephalopathy treated with nivolumab.
Hoang E; Bartlett NL; Goyal MS; Schmidt RE; Clifford DB
J Neurovirol; 2019 Apr; 25(2):284-287. PubMed ID: 30864100
[TBL] [Abstract][Full Text] [Related]
9. Progressive multifocal leukoencephalopathy in Zambia is caused by JC virus with prototype regulatory region.
Mubanga E; Patel A; Siddiqi OK; Hanson BA; Dang X; Lakhi S; Mulundu G; Bender N; Koralnik IJ
J Neurovirol; 2019 Aug; 25(4):475-479. PubMed ID: 31028690
[TBL] [Abstract][Full Text] [Related]
10. JC Polyomavirus, progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome: a review.
Harypursat V; Zhou Y; Tang S; Chen Y
AIDS Res Ther; 2020 Jul; 17(1):37. PubMed ID: 32631361
[TBL] [Abstract][Full Text] [Related]
11. Host-Immune Interactions in JC Virus Reactivation and Development of Progressive Multifocal Leukoencephalopathy (PML).
Khalili A; Craigie M; Donadoni M; Sariyer IK
J Neuroimmune Pharmacol; 2019 Dec; 14(4):649-660. PubMed ID: 31452013
[TBL] [Abstract][Full Text] [Related]
12. Promise and Challenges of Checkpoint Inhibitor Therapy for Progressive Multifocal Leukoencephalopathy in HIV.
Corey S; Smith BR; Cortese ICM
Curr HIV/AIDS Rep; 2022 Dec; 19(6):580-591. PubMed ID: 36181625
[TBL] [Abstract][Full Text] [Related]
13. Lack of specific T- and B-cell clonal expansions in multiple sclerosis patients with progressive multifocal leukoencephalopathy.
Bertoli D; Sottini A; Capra R; Scarpazza C; Bresciani R; Notarangelo LD; Imberti L
Sci Rep; 2019 Nov; 9(1):16605. PubMed ID: 31719595
[TBL] [Abstract][Full Text] [Related]
14. Immunology of progressive multifocal leukoencephalopathy.
Jelcic I; Jelcic I; Faigle W; Sospedra M; Martin R
J Neurovirol; 2015 Dec; 21(6):614-22. PubMed ID: 25740538
[TBL] [Abstract][Full Text] [Related]
15. Progressive multifocal leukoencephalopathy: JC virus induced demyelination in the immune compromised host.
Hou J; Major EO
J Neurovirol; 2000 May; 6 Suppl 2():S98-S100. PubMed ID: 10871795
[TBL] [Abstract][Full Text] [Related]
16. Molecular regulation of JC virus tropism: insights into potential therapeutic targets for progressive multifocal leukoencephalopathy.
Marshall LJ; Major EO
J Neuroimmune Pharmacol; 2010 Sep; 5(3):404-17. PubMed ID: 20401541
[TBL] [Abstract][Full Text] [Related]
17. Progressive multifocal leukoencephalopathy.
Berger JR
Curr Neurol Neurosci Rep; 2007 Nov; 7(6):461-9. PubMed ID: 17999891
[TBL] [Abstract][Full Text] [Related]
18. Update on progressive multifocal leukoencephalopathy.
Steiner I; Berger JR
Curr Neurol Neurosci Rep; 2012 Dec; 12(6):680-6. PubMed ID: 22991070
[TBL] [Abstract][Full Text] [Related]
19. Progressive multifocal leukoencephalopathy associated with a lymphoproliferative disorder treated with pembrolizumab.
Holmes A; Wellings T; Walsh O; Rowlings P
J Neurovirol; 2020 Dec; 26(6):961-963. PubMed ID: 32910430
[TBL] [Abstract][Full Text] [Related]
20. Critical role of JC virus-specific CD4 T-cell responses in preventing progressive multifocal leukoencephalopathy.
Gasnault J; Kahraman M; de Goër de Herve MG; Durali D; Delfraissy JF; Taoufik Y
AIDS; 2003 Jul; 17(10):1443-9. PubMed ID: 12824781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]